Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients With Hepatic Impairment. [electronic resource]
Producer: 20161020Description: e11-4 p. digitalISSN:- 2152-2669
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.